摘要 |
Compounds of formula I, wherein R<SUP>1</SUP>, n, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>7</SUP>, R<SUP>8 </SUP>and P are as defined in the specification, salts, solvates or solvated salts thereof, processes for their preparation, new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and the use of said compounds in therapy.
|